Efficacy, Durability, and Tolerability of Dolutegravir/Lamivudine and Dolutegravir/Rilpivirine for the Treatment of HIV in a Real-World Setting in Belgium

Rakan Nasreddine (Speaker), Allard, S. (Contributor)

Activity: Talk or presentationTalk or presentation at a conference

Period6 Apr 20229 Apr 2022
Event titleAFRAVIH 2022
Event typeConference
LocationMarseille, France